Correlation Between Biotechnology Fund and Sp Midcap
Can any of the company-specific risk be diversified away by investing in both Biotechnology Fund and Sp Midcap at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Fund and Sp Midcap into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Fund Class and Sp Midcap 400, you can compare the effects of market volatilities on Biotechnology Fund and Sp Midcap and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Fund with a short position of Sp Midcap. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Fund and Sp Midcap.
Diversification Opportunities for Biotechnology Fund and Sp Midcap
0.99 | Correlation Coefficient |
No risk reduction
The 3 months correlation between Biotechnology and RYCKX is 0.99. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Fund Class and Sp Midcap 400 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sp Midcap 400 and Biotechnology Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Fund Class are associated (or correlated) with Sp Midcap. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sp Midcap 400 has no effect on the direction of Biotechnology Fund i.e., Biotechnology Fund and Sp Midcap go up and down completely randomly.
Pair Corralation between Biotechnology Fund and Sp Midcap
Assuming the 90 days horizon Biotechnology Fund Class is expected to under-perform the Sp Midcap. But the mutual fund apears to be less risky and, when comparing its historical volatility, Biotechnology Fund Class is 1.15 times less risky than Sp Midcap. The mutual fund trades about -0.02 of its potential returns per unit of risk. The Sp Midcap 400 is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 3,681 in Sp Midcap 400 on November 9, 2024 and sell it today you would earn a total of 55.00 from holding Sp Midcap 400 or generate 1.49% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biotechnology Fund Class vs. Sp Midcap 400
Performance |
| Timeline |
| Biotechnology Fund Class |
| Sp Midcap 400 |
Biotechnology Fund and Sp Midcap Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biotechnology Fund and Sp Midcap
The main advantage of trading using opposite Biotechnology Fund and Sp Midcap positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Fund position performs unexpectedly, Sp Midcap can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sp Midcap will offset losses from the drop in Sp Midcap's long position.| Biotechnology Fund vs. Thrivent Natural Resources | Biotechnology Fund vs. Franklin Natural Resources | Biotechnology Fund vs. Transamerica Mlp Energy | Biotechnology Fund vs. Pimco Energy Tactical |
| Sp Midcap vs. Financial Services Portfolio | Sp Midcap vs. Putnam Global Financials | Sp Midcap vs. Prudential Financial Services | Sp Midcap vs. Financial Industries Fund |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |